# Trade Mark Journal No.2025/051 19 December 2025

## WO0000001890404 (5,42)

Office of origin: United States of America

Date of International Registration:4 November 2025
Date of designation in the UK: 4 November 2025

International priority date claimed: 11 June 2025 (United States of America) (99229675)

Class 5
  Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system-related diseases and disorders.
Class 42
  Pharmaceutical research and development; drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.

ImmunEdge, Inc.

Representative: Aaron D. Hendelman Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto CA 94304-1050, UNITED STATES OF AMERICA